Clinical Study of Yiqi-yangyin-jiedu Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma Patients With Activating EGFR Mutation
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Gefitinib (Primary)
- Indications Adenocarcinoma; Liver cancer
- Focus Therapeutic Use
- 08 Apr 2021 New trial record